Although the differences were not statistically significant, the median age at the onset of KDT was higher in SLC2A1(+)-group (8.8 versus 4.9 years), and in the epilepsy group (4.5 versus 3.5 years). The gene discussed is SLC2A1; the disease is epilepsy.